Global Rare Disease Coverage

Rare Diseases, Orphan Drugs, Genetic Disorders

Global Accessibility of Spinal Muscular Atrophy (SMA) Treatment: Current Status Analysis

Featured Rare Disease Story

Global Accessibility of Spinal Muscular Atrophy (SMA) Treatment: Current Status Analysis

This article analyzes the worldwide accessibility of spinal muscular atrophy (SMA) therapies, examining treatment advances, healthcare disparities, reimbursement systems, supply chain challenges, and future trends toward equitable access for rare disease patients.